These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5496789)

  • 21. A slow-release preparation of isoniazid: therapeutic efficacy and adverse side-effects.
    Tripathy SP
    Bull Int Union Tuberc; 1976; 51(1):133-41. PubMed ID: 1030274
    [No Abstract]   [Full Text] [Related]  

  • 22. [Historical multifocal tuberculosis in an African (apropos of a case report)].
    Gendron Y; Barbabe P; Charles D; Delmarre B
    Med Trop (Mars); 1984; 44(4):375-8. PubMed ID: 6521633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Urgent problems of antibacterial treatment of pulmonary tuberculosis].
    Pilipchuk NS
    Vrach Delo; 1981 Jan; (1):47-9. PubMed ID: 7010782
    [No Abstract]   [Full Text] [Related]  

  • 24. 'Intermittent chemotherapy' in intracardially infected tuberculous guinea pigs.
    Gupta SK; Mathur IS
    Experientia; 1969 Aug; 25(8):894. PubMed ID: 5348574
    [No Abstract]   [Full Text] [Related]  

  • 25. [Sodium metabisulfite inhibition of the reaction between isoniazid and streptomycin in solution].
    Aleksandrova AE; Moldaver BL; Borisova OA; Vishnevskiĭ BI; Il'ina TB
    Probl Tuberk; 1983 Aug; (8):54-7. PubMed ID: 6356127
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect and treatment problems of secondary antitubercular agents].
    Dissmann E
    Wien Med Wochenschr; 1966 Nov; 116(47):996-8. PubMed ID: 6011782
    [No Abstract]   [Full Text] [Related]  

  • 27. [Intramuscular administration of tubazid and streptomycin in a single injection during treatment of tuberculosis].
    Smirnov GA; Abdullina ZR
    Probl Tuberk; 1972; 50(7):79-80. PubMed ID: 5050807
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparison of the therapeutic efficacy of the so-called heavy and lightened antitubercular regimens].
    Bretton R; Monthaneix C; Coulibaly C; Bretton G; Rey D
    Bull Int Union Tuberc; 1985; 60(1-2):34-5. PubMed ID: 4074971
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical experience of acceptability of slow release matrix isoniazid.
    Polansky F; Viznerova S; Vodrazkova A; Stott H
    Bull Int Union Tuberc; 1976; 51(1):155-8. PubMed ID: 1030276
    [No Abstract]   [Full Text] [Related]  

  • 30. [Forum on paraplegia due to Pott's disease].
    Aboulker J; Cauchoix J; Evrard J; Ferrand L; Weber R
    Rev Chir Orthop Reparatrice Appar Mot; 1968; 54(7):677-87. PubMed ID: 4237137
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment modalities applied to tuberculosis patients in a French department. Hautes-Pyrénées, 1973 to 1980].
    Hetrick G; Humarau H
    Rev Fr Mal Respir; 1983; 11(6):883-7. PubMed ID: 6669799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of restriction fragment length polymorphism (RFLP) in epidemiology of tuberculosis].
    Gómez Marín JE; Rigouts L; Villegas Londoño LE; Portaels F
    Bol Oficina Sanit Panam; 1995 Jul; 119(1):1-10. PubMed ID: 7654295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Results of planned treatment of tuberculosis, under field conditions, with a therapeutic regimen consisting of isoniazid, rifampicin and streptomycin].
    González Montaner LJ; Palma Beltrán O; Abbate E; Dambrosi A; Mosca C
    Bull Int Union Tuberc; 1983 Jun; 58(2):108-10. PubMed ID: 6360262
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pluriresistant tuberculous bacilli in developing countries: value of sensitivity tests with antibiotic combinations].
    Chataigneau P; Castets M
    Rev Tuberc Pneumol (Paris); 1970; 34(3):454-6. PubMed ID: 5510438
    [No Abstract]   [Full Text] [Related]  

  • 35. Four-drug initial therapy for TB is standard treatment.
    Brennan PJ; MacGregor RR
    Pa Med; 1996 Jan; 99(1):18-9. PubMed ID: 8927398
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative study of biweekly streptomycin and isoniazid with daily P.A.S. and isoniazid regimens in the treatment of pulmonary tuberculosis.
    Mathur JB; Bahadur P; Agnihotri CB
    J Indian Med Assoc; 1967 Aug; 49(4):162-5. PubMed ID: 5594009
    [No Abstract]   [Full Text] [Related]  

  • 37. [Controlled study of a bi-weekly treatment with isoniazid and ethionamide].
    Larbaoui D; Chaulet P; Grosset J; Abderrahim K; Zirout A
    Bull Int Union Tuberc; 1970 Jun; 43():282-8. PubMed ID: 5425556
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug-resistant tuberculosis in Budapest.
    Fodor T; Vadász I; Lõrinczi I
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.
    Lee H; Cho SN; Bang HE; Lee JH; Bai GH; Kim SJ; Kim JD
    Int J Tuberc Lung Dis; 2000 May; 4(5):441-7. PubMed ID: 10815738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biweekly treatment of pulmonary tuberculosis with isoniazid and streptomycin, with or without initial continuous phase. Results obtained in Algiers].
    Larbaoui D; Abderrahim K
    Rev Tuberc Pneumol (Paris); 1968 Jun; 32(4):572-3. PubMed ID: 5758995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.